Literature DB >> 31806428

Pro-inflammatory cytokines are associated with podocyte damage and proximal tubular dysfunction in the early stage of diabetic kidney disease in type 2 diabetes mellitus patients.

Oana Milas1, Florica Gadalean2, Adrian Vlad3, Victor Dumitrascu4, Silvia Velciov1, Cristina Gluhovschi5, Flaviu Bob1, Roxana Popescu6, Sorin Ursoniu7, Dragos Catalin Jianu8, Petru Matusz9, Agneta-Maria Pusztai10, Alina Secara1, Anca Simulescu1, Maria Stefan1, Mihaela Patruica1, Flaviu Petrica11, Daliborca Vlad4, Ligia Petrica12.   

Abstract

AIMS: To evaluate if there is a link between inflammation (expressed by inflammatory cytokines) and the early stage of diabetic kidney disease (DKD), as shown by markers of podocyte damage and proximal tubular (PT) dysfunction.
METHODS: In this study were enrolled 117 type 2 DM patients (36-normoalbuminuria, 42-microalbuminuria, 39- macroalbuminuria), and 11 healthy subjects. Serum and urinary IL-1 alpha, IL-8, IL-18, urinary albumin:creatinine ratio (UACR), eGFR, biomarkers of podocyte damage (podocalyxin, synaptopodin, nephrin) and of PT dysfunction (KIM-1, NAG) were assessed.
RESULTS: In multivariable regression urinary Il-1 alpha correlated positively with podocalyxin and NAG (p < 0.0001, R2= 0.57); urinary IL-8 correlated directly with synaptopodin, NAG, nephrin, and KIM-1 (p < 0.0001, R2 = 0.67); urinary IL-18 correlated directly with synaptopodin, NAG, and nephrin (p < 0.0001, R2 = 0.59). Serum IL-1 alpha correlated positively with nephrin, synaptopodin, NAG (P < 0.0001, R2 = 0.68); serum IL-8 correlated directly with synaptopodin and NAG (p < 0.0001, R2 = 0.66); serum IL-18 correlated directly with NAG, KIM-1, and podocalyxin (p < 0.0001, R2=0.647).
CONCLUSIONS: Pro-inflammatory interleukins are associated with podocyte injury and PT dysfunction in early DKD. These could exert a key role in the pathogenesis of early DKD, before the development of albuminuria.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Albuminuria; Diabetic kidney disease; Interleukins; Podocyte biomarkers; Proximal tubular dysfunction

Mesh:

Substances:

Year:  2019        PMID: 31806428     DOI: 10.1016/j.jdiacomp.2019.107479

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  11 in total

Review 1.  Lipid deposition and metaflammation in diabetic kidney disease.

Authors:  Alla Mitrofanova; Antonio M Fontanella; Sandra Merscher; Alessia Fornoni
Journal:  Curr Opin Pharmacol       Date:  2020-11-01       Impact factor: 5.547

2.  Tubular injury in diabetic ketoacidosis: Results from the diabetic kidney alarm study.

Authors:  Federica Piani; Isabella Melena; Cameron Severn; Linh T Chung; Carissa Vinovskis; David Cherney; Laura Pyle; Carlos A Roncal-Jimenez; Miguel A Lanaspa; Arleta Rewers; Daniël H van Raalte; Wassim Obeid; Chirag Parikh; Robert G Nelson; Meda E Pavkov; Kristen J Nadeau; Richard J Johnson; Petter Bjornstad
Journal:  Pediatr Diabetes       Date:  2021-09-06       Impact factor: 4.866

3.  High-Resolution Tandem Mass Spectrometry Identifies a Particular Ganglioside Pattern in Early Diabetic Kidney Disease of Type 2 Diabetes Mellitus Patients.

Authors:  Anca Suteanu-Simulescu; Alina Diana Zamfir; Raluca Ica; Mirela Sarbu; Cristian V A Munteanu; Florica Gadalean; Adrian Vlad; Flaviu Bob; Dragos Catalin Jianu; Ligia Petrica
Journal:  Molecules       Date:  2022-04-21       Impact factor: 4.927

4.  Astragalus membranaceus Injection Suppresses Production of Interleukin-6 by Activating Autophagy through the AMPK-mTOR Pathway in Lipopolysaccharide-Stimulated Macrophages.

Authors:  Xiaoyan Zhang; Taigang Liang; Wanxia Yang; Lanfang Zhang; Shuting Wu; Chaoqun Yan; Qingshan Li
Journal:  Oxid Med Cell Longev       Date:  2020-07-04       Impact factor: 6.543

Review 5.  Metformin Protects against Podocyte Injury in Diabetic Kidney Disease.

Authors:  Sanna Lehtonen
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-10

Review 6.  Update on pathogenesis and diagnosis flow of normoalbuminuric diabetes with renal insufficiency.

Authors:  Le Deng; Wenjie Li; Gaosi Xu
Journal:  Eur J Med Res       Date:  2021-12-11       Impact factor: 2.175

Review 7.  Involvement of Inflammasome Components in Kidney Disease.

Authors:  Ana Karina Aranda-Rivera; Anjali Srivastava; Alfredo Cruz-Gregorio; José Pedraza-Chaverri; Shrikant R Mulay; Alexandra Scholze
Journal:  Antioxidants (Basel)       Date:  2022-01-27

8.  Clonal Hematopoiesis of Indeterminate Potential and Diabetic Kidney Disease: A Nested Case-Control Study.

Authors:  Sara Denicolò; Verena Vogi; Felix Keller; Stefanie Thöni; Susanne Eder; Hiddo J L Heerspink; László Rosivall; Andrzej Wiecek; Patrick B Mark; Paul Perco; Johannes Leierer; Andreas Kronbichler; Marion Steger; Simon Schwendinger; Johannes Zschocke; Gert Mayer; Emina Jukic
Journal:  Kidney Int Rep       Date:  2022-02-03

Review 9.  Therapeutic Potential of Photobiomodulation for Chronic Kidney Disease.

Authors:  Ji Bian; Ann Liebert; Brian Bicknell; Xin-Ming Chen; Chunling Huang; Carol A Pollock
Journal:  Int J Mol Sci       Date:  2022-07-21       Impact factor: 6.208

Review 10.  The role of inflammation in diabetic kidney disease.

Authors:  Su Woong Jung; Ju-Young Moon
Journal:  Korean J Intern Med       Date:  2021-07-01       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.